Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2003
05/01/2003WO2003035843A2 Screening system for modulators of her2 mediated transcription and her2 modulators identifed thereby
05/01/2003WO2003035842A2 Hybridization control of sequence variation
05/01/2003WO2003035841A2 Methods and systems for dynamic gene expression profiling
05/01/2003WO2003035840A2 69583 and 85924, novel human protein kinase family members and uses therefor
05/01/2003WO2003035838A2 Stem cells that transform to beating cardiomyocytes
05/01/2003WO2003035834A2 Compositions and methods for making mutations in cell lines and animals
05/01/2003WO2003035833A2 Modifier of the p53 pathway and methods of use
05/01/2003WO2003035831A2 Lrrcaps as modifiers of the p53 pathway and methods of use
05/01/2003WO2003035829A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
05/01/2003WO2003035826A2 Genetic screening methods
05/01/2003WO2003035693A2 Crystals of cytochrome p450 2c9, structures thereof and their use
05/01/2003WO2003035691A1 Apolipoprotein a-i mutation useful for diagnosis and treatment of cardiovascular diseases
05/01/2003WO2003035684A1 Ee3-protein family and corresponding dna sequences
05/01/2003WO2003035681A2 Mycobacterial genes down-regulated during latency
05/01/2003WO2003035679A2 Molecules
05/01/2003WO2003035678A2 Sperm factor sequences
05/01/2003WO2003035671A2 Methods for detecting genetic haplotypes by interaction with probes
05/01/2003WO2003035670A2 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
05/01/2003WO2003035665A1 Modified l-nucleic acid
05/01/2003WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
05/01/2003WO2003035477A1 Specimen vial sealing apparatus and method
05/01/2003WO2003035264A1 System of handling dielectric particles, particularly biological cells, by means of dielectrophoresis
05/01/2003WO2003035259A2 Arrays with hairpin structures
05/01/2003WO2003035229A2 Integrated fluidic device for sample preparation and assay
05/01/2003WO2003035048A2 Methods for the treatment of osteoarthritis and compositions thereof
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2003034903A2 Psma antibodies and protein multimers
05/01/2003WO2003034896A2 Methods of diagnosis of autoimmune disease
05/01/2003WO2003020985B1 Detection of genetic sequences using a bipartite probe
05/01/2003WO2003008623A3 Methylation analysis using nicking agents
05/01/2003WO2003008622A3 Exponential nucleic acid amplification using nicking endonucleases
05/01/2003WO2003006684A3 Device and method for detecting photosynthesis inhibition
05/01/2003WO2003006675A3 Methods and devices based upon a novel form of nucleic acid duplex on a surface
05/01/2003WO2003004680A3 Atherosclerosis susceptibility gene locus 1 (athsq1) and 2 (athsq2)
05/01/2003WO2002101339A3 Imaging and analyzing parameters of small moving objects such as cells
05/01/2003WO2002101022A3 Method for rapid amplification of dna
05/01/2003WO2002099432A3 Quinacridone labelling reagents for fluorescence detection of biological materials
05/01/2003WO2002099071A3 Hybridization normalization methods
05/01/2003WO2002099055A3 Cips as modifiers of the p53 pathway and method of use
05/01/2003WO2002099046A3 Spo11 as modifier of the p53 pathway and methods of use
05/01/2003WO2002098444A3 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/01/2003WO2002098347A3 Methods and compositions that affect melanogenesis (pfi-016cip/pct)
05/01/2003WO2002090498A3 A high throughput assay for identification of gene expression modifiers
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002081513A3 Disease-associated protein
05/01/2003WO2002075280A3 Examination device and method for examination of chemical and/or biological samples
05/01/2003WO2002072887A3 Immobilisation of ligands using saccharides
05/01/2003WO2002066983A3 Bioassay device for detecting molecular events
05/01/2003WO2002063007A3 TIMM8b-RELATED PROTEIN
05/01/2003WO2002059356A3 Method for screening compounds for activity in treating an osteoclast related bone disease
05/01/2003WO2002057496A9 Gene expression profiling of endothelium in alzheimer's disease
05/01/2003WO2002055995A3 Method and system for modeling cellular metabolism
05/01/2003WO2002055988A3 Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
05/01/2003WO2002055741A3 Method for detection of drug-induced mutations in the hiv reverse transcriptase gene
05/01/2003WO2002055703A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/01/2003WO2002053018A3 Method of detecting polymorphisms associated with breast carcinoma in mhc genes
05/01/2003WO2002053017A3 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
05/01/2003WO2002048385A3 Compositions and methods for the release of nucleic acid molecules from solid matrices
05/01/2003WO2002046476A3 Genotyping using partially-complementary probes
05/01/2003WO2002046463A9 Nucleic acid extraction method and kit
05/01/2003WO2002044407A3 Glyphosate resistant transgenic sugar beet characterised by a specific transgene insertion (t227-1), methods and primers for the detection of said insertion
05/01/2003WO2002042500A3 Apparatus and method for electrophoretic microspot concentration
05/01/2003WO2002042485A9 Methods and computer software products for selecting nucleic acid probes
05/01/2003WO2002042460A3 Compositions and methods relating to colon specific genes and proteins
05/01/2003WO2002038600A3 C. elegans genes involved in viability and/or reproduction and uses thereof
05/01/2003WO2002034948A9 Candidate region mismatch scanning for genotyping and mutation detection
05/01/2003WO2002029093A3 Method for selecting nucleic acids that bond with high-affinity to a target
05/01/2003WO2002027023A3 Genetic determinants for dermal inflammation and immunity
05/01/2003WO2002026250A3 Vaccines for proliferative ileitis
05/01/2003WO2002022851A3 Novel tumor-associated marker
05/01/2003WO2002004671A3 Improved binding interactions in dipstick assays
05/01/2003WO2002004663A3 A nucleic acid-based method for tree phenotype prediction
05/01/2003WO2001098478A3 Clk-2, cex-7 and coq-4 genes, and uses thereof
05/01/2003WO2001079561A3 Alpha-2 adrenergic receptor polymorphisms
05/01/2003WO2001079291A3 Secreted proteins
05/01/2003WO2001066572A3 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
05/01/2003WO2001024681A3 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
05/01/2003WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
05/01/2003US20030084483 Methods and means for modification of plant characteristics
05/01/2003US20030084471 Methods and compositions for RNA interference
05/01/2003US20030084466 System and method for controlling male fertility
05/01/2003US20030083575 Capillary array-based sample screening
05/01/2003US20030083490 Coupling of H-phosphonate with a nucleoside alcohol to form the diester; oxidation with sulfur transfer agent to form a phosphorothioate triester
05/01/2003US20030083487 Progestogen receptor polypeptides, transgenic cells in which genes encoding said polypeptides are introduced and method for detecting disruptors for progestogens by using said transgenic cells
05/01/2003US20030083485 Nucleotide sequences coding polypeptide for use the treament of cardiovascular disorders
05/01/2003US20030083483 Molecular interaction sites of vimentin RNA and methods of modulating the same
05/01/2003US20030083481 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of prostate cancer
05/01/2003US20030083479 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083468 Polypeptide for use in the treatment of inflammation and liver disorders
05/01/2003US20030083467 Fusion proteins for use in the treatment of tumors and nervous sytem disorders
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083461 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/01/2003US20030083302 An oligonucleotides are specifically hybridizable with targeted nucleic acids to inhibit the gene expression of DNA helicases
05/01/2003US20030083297 Antisense modulation of daxx expression
05/01/2003US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
05/01/2003US20030083288 Treatment of glaucoma with use of malanocytes to reduce production of melanin; medical diagnosis
05/01/2003US20030083269 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment
05/01/2003US20030083253 Polynucleotide encoding autoantigens associated with endometriosis
05/01/2003US20030083242 Methods and compositions for treating or preventing peripheral neuropathies
05/01/2003US20030082831 Apparatus for use in the synthesis of preferential biopolymers
1 ... 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 ... 3003